Duloxetine related binge eating behaviors: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 8, 2009, Pages 1581-1582

  Lai, Chien Han ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; DULOXETINE;

ABDOMINAL DISCOMFORT; ADULT; BINGE EATING DISORDER; CASE REPORT; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; DISTRESS SYNDROME; DRUG DOSE INCREASE; EXCITEMENT; FEMALE; HAMILTON SCALE; HELPLESSNESS; HUMAN; INSOMNIA; LETTER; MAJOR DEPRESSION; NAUSEA; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; VOMITING; WEIGHT GAIN;

ADULT; ANTIDEPRESSIVE AGENTS; BINGE-EATING DISORDER; DEPRESSION; FEMALE; HUMANS; THIOPHENES;

EID: 71549116106     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.09.016     Document Type: Letter

References (12)

1. Bernardi S., and Pallanti S. Successful duloxetine treatment of a binge eating disorder: a case report. J Psychopharmacol (2008)
2. Billes S.K., and Cowley M.A. Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis. Neuropsychopharmacology 33 (2008) 1287-1297
3. Capasso A., Putrella C., and Milano W. Recent clinical aspects of eating disorders. Rev Recent Clin Trials 4 (2009) 63-69
4. Hazen E., and Fava M. Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report. J Psychopharmacol 20 (2006) 723-724
5. Jimerson D.C., Lesem M.D., Kaye W.H., and Brewerton T.D. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49 (1992) 132-138
6. Kaye W.H., and Weltzin T.E. Neurochemistry of bulimia nervosa. J Clin Psychiatry 52 Suppl:21-8 (1991)
7. Koch S., Hemrick-Luecke S.K., Thompson L.K., Evans D.C., Threlkeld P.G., Nelson D.L., et al. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats. Neuropharmacology 45 (2003) 935-944
8. Kuikka J.T., Tammela L., Karhunen L., Rissanen A., Bergstrom K.A., Naukkarinen H., et al. Reduced serotonin transporter binding in binge eating women. Psychopharmacology (Berl) 155 (2001) 310-314
9. Leibowitz S.F., and Alexander J.T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44 (1998) 851-864
10. Leombruni P., Lavagnino L., Gastaldi F., Vasile A., and Fassino S. Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial. Hum Psychopharmacol 24 (2009) 483-488
11. Lopez-Munoz F., Alamo C., Rubio G., Garcia-Garcia P., and Pardo A. Reboxetine combination in treatment-resistant depression to selective serotonin reuptake inhibitors. Pharmacopsychiatry 40 (2007) 14-19
12. Wellman P.J. Norepinephrine and the control of food intake. Nutrition 16 (2000) 837-842